Philip J. Vickers - Net Worth and Insider Trading
Philip J. Vickers Net Worth
The estimated net worth of Philip J. Vickers is at least $23,901 dollars as of 2024-06-10. Philip J. Vickers is the Director of Revance Therapeutics Inc and owns about 6,150 shares of Revance Therapeutics Inc (RVNC) stock worth over $16,605. Philip J. Vickers is also the Director of Avrobio Inc and owns about 4,800 shares of Avrobio Inc (AVRO) stock worth over $7,296. Details can be seen in Philip J. Vickers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Philip J. Vickers has not made any transactions after 2021-07-07 and currently still holds the listed stock(s).
Transaction Summary of Philip J. Vickers
Philip J. Vickers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Philip J. Vickers owns 2 companies in total, including Avrobio Inc (AVRO) , and Revance Therapeutics Inc (RVNC) .
Click here to see the complete history of Philip J. Vickers’s form 4 insider trades.
Insider Ownership Summary of Philip J. Vickers
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVRO | Avrobio Inc | 2021-07-07 | director |
| RVNC | Revance Therapeutics Inc | 2018-03-16 | director |
Philip J. Vickers Latest Holdings Summary
Philip J. Vickers currently owns a total of 2 stocks. Among these stocks, Philip J. Vickers owns 6,150 shares of Revance Therapeutics Inc (RVNC) as of March 16, 2018, with a value of $16,605 and a weighting of 69.47%. Philip J. Vickers also owns 4,800 shares of Avrobio Inc (AVRO) as of July 7, 2021, with a value of $7,296 and a weighting of 30.53%.
Latest Holdings of Philip J. Vickers
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2018-03-16 | 6,150 | 2.70 | 16,605 |
| AVRO | Avrobio Inc | 2021-07-07 | 4,800 | 1.52 | 7,296 |
Holding Weightings of Philip J. Vickers
Philip J. Vickers Form 4 Trading Tracker
According to the SEC Form 4 filings, Philip J. Vickers has made a total of 0 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years. The most-recent trade in Revance Therapeutics Inc is the acquisition of 3,150 shares on March 16, 2018, which cost Philip J. Vickers around $98,406.
According to the SEC Form 4 filings, Philip J. Vickers has made a total of 1 transactions in Avrobio Inc (AVRO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Avrobio Inc is the acquisition of 4,800 shares on July 7, 2021, which cost Philip J. Vickers around $40,080.
Insider Trading History of Philip J. Vickers
- 1
Philip J. Vickers Trading Performance
GuruFocus tracks the stock performance after each of Philip J. Vickers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Philip J. Vickers is -15.82%. GuruFocus also compares Philip J. Vickers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Philip J. Vickers within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Philip J. Vickers's insider trading performs compared to the benchmark.
Performance of Philip J. Vickers
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.98 | | | | | |
| Relative Return to S&P 500(%) | -1.53 | | | | | |
Philip J. Vickers Ownership Network
Philip J. Vickers Owned Company Details
What does Avrobio Inc do?
Who are the key executives at Avrobio Inc?
Philip J. Vickers is the director of Avrobio Inc. Other key executives at Avrobio Inc include Chief Technology Officer Azadeh Golipour , Chief Medical Officer Essra Ridha , and Chief Scientific Officer Christopher Mason .
Avrobio Inc (AVRO) Insider Trades Summary
Over the past 18 months, Philip J. Vickers made no insider transaction in Avrobio Inc (AVRO). Other recent insider transactions involving Avrobio Inc (AVRO) include a net purchase of 766,635 shares made by Braden Michael Leonard ,
In summary, during the past 3 months, insiders sold 0 shares of Avrobio Inc (AVRO) in total and bought 766,635 shares, with a net purchase of 766,635 shares. During the past 18 months, 0 shares of Avrobio Inc (AVRO) were sold and 766,635 shares were bought by its insiders, resulting in a net purchase of 766,635 shares.
Avrobio Inc (AVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avrobio Inc Insider Transactions
Philip J. Vickers Mailing Address
Above is the net worth, insider trading, and ownership report for Philip J. Vickers. You might contact Philip J. Vickers via mailing address: C/o Revance Therapeutics, Inc., 7555 Gateway Boulevard, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
